'Coronary revascularisation' presentation slideshows

P rof . Mirza Dili ?, MD, PhD, FESC, FACC Clinical Center Sarajevo

Stroke prevention in atrial fibrillation. P rof . Mirza Dili ?, MD, PhD, FESC, FACC Clinical Center Sarajevo Director Internal Clinics and Departments. Epidemiological data.

509 views • 43 slides

The results of the SHARP trial

The results of the SHARP trial. SHARP: Rationale. Risk of vascular events is high among patients with chronic kidney disease Lack of clear association between cholesterol level and vascular disease risk Pattern of vascular disease is atypical, with a large proportion being non-atherosclerotic

294 views • 29 slides

Heberden W. Some account of a disorder of the breast.

Angina.

530 views • 26 slides

302 views • 14 slides

SHARP trial

SHARP trial. Study of Heart and Renal Protection : a randomised placebo-controlled trial The e?ects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with CKD L ancet June 9, 2011. To assess the safety and e?cacy of reducing LDL cholesterol in CKD

567 views • 11 slides